Questions Linger in Del Harassment Case
When Del Laboratories, a cosmetics and pharmaceutical company, agreed to pay $1.185 million last week to settle a Government complaint that its chief executive had sexually harassed women employees, women's groups hailed the action as a step toward discouraging such behavior. But many lawyers and experts on the way companies are managed see nothing to cheer about. They say the behavior of the company's board of directors fell far short of what shareholders should expect. Among their questions are whether the Del board was too dominated by friends and associates of the chief executive, Dan K. Wassong, with no truly independent directors who could step back and act dispassionately. They also asked whether a separate board committee should have guided the company's response. And they wondered why Mr. Wassong was allowed to remain deeply involved in the board's deliberations.